Qvar Redihaler Aerosol, Metered
Pricing Report NDC 59310-302-40

Current NADAC: $20.56410 per GM · Effective Aug 19, 2026

Current Package Pricing Information

The current wholesale acquisition cost for Qvar Redihaler (NDC 59310-302-40) is $20.56410 per GM. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Aug 19, 2026.

As a a human prescription drug provided by Teva Respiratory, Llc, this medication is distributed in a 1 INHALER in 1 CARTON / 1 CANISTER in 1 INHALER / 120 AEROSOL, METERED in 1 CANISTER configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$20.56410
Per GM

Effective Date
Aug 19, 2026
Data Status
As of Sep 09, 2026
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 INHALER in 1 CARTON / 1 CANISTER in 1 INHALER / 120 AEROSOL, METERED in 1 CANISTER
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Apr 2018, the NADAC wholesale price for (NDC ) has moved within a range of $15.25490 to $20.57999 per GM. Over this 8 years and 4 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$15.2549 - $20.5800
Market Volatility
34.91% Variance
Latest Trend
0.03%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Aug 19, 2026 $20.56410 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Jul 22, 2026 $20.57048 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Jun 17, 2026 $20.56909 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
May 20, 2026 $20.57999 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Jan 01, 2026 $20.56937 GMC/I - Chain or Independent PharmacyCode 2, 5B - Brand
Jan 01, 2026 $20.56937 GMC/I - Chain or Independent PharmacyCode 3, 5B - Brand
Jan 01, 2026 $20.56937 GMC/I - Chain or Independent PharmacyCode 4, 5B - Brand
Dec 17, 2025 $19.77825 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Nov 19, 2025 $19.77684 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Oct 22, 2025 $19.77893 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Sep 17, 2025 $19.78189 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Aug 20, 2025 $19.78544 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026